Indianapolis — Regenstrief Institute research scientists are presenting some of the institute’s latest research on patient engagement and advocacy at the Society of General Internal Medicine Annual Meeting in Washington, D.C., May 8-11. The meeting covers the breadth and depth of general internal medicine. This year’s theme is Courage to Lead: Equity, Engagement, and Advocacy…
IMAGE: A machine learning algorithm can detect signs of anxiety and depression in the speech patterns of young children, potentially providing a fast and easy way of diagnosing conditions that are… view more A machine learning algorithm can detect signs of anxiety and depression in the speech patterns of young children, potentially providing a fast and…
BALTIMORE, MD, May 6, 2019- Neurodegenerative diseases like multiple sclerosis (MS) affect millions of people worldwide and occur when parts of the nervous system lose function over time. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered that a type of skin-related stem cell could be used to help regenerate myelin sheaths,…
A new study from the University of Georgia pinpoints lifestyle factors that could lead to hardened arteries. One of the largest of its kind, the study performed an untargeted metabolomics profile of over 1,200 participants of the Bogalusa Heart Study to identify metabolites linked to the hardening of arteries. Hardening arteries, or arterial stiffness, is…
IMAGE: Dr. Zhandong Liu view more Credit: Baylor College of Medicine Like finding a needle in a haystack, identifying genes that are involved in particular diseases can be an arduous and time consuming process. Looking to improve this process, a team led by researchers at Baylor College of Medicine has developed a new bioinformatics tool that…
A new study published in the Journal of Infectious Diseases found that immediate treatment initiation for HIV infection has improved since local and federal guidelines began to recommend universal treatment for all persons diagnosed with HIV, regardless of their disease stage. Despite notable improvements, nearly 25 percent of New York City residents with a new…
IMAGE: Dr. VandeWoude discusses research with Elliott Chiu, DVM/PhD student (left) and Research Associate Mary Nehring. view more Credit: William A. Cotton/CSU Photography Dr. Susan VandeWoude learned the news at Dulles Airport while returning from Washington, D.C., on April 30: She had been elected to join the National Academy of Sciences, one of the highest honors…
An international clinical trial has found that a new drug for Huntington disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating disease in patients. In a study published today in the New England Journal of Medicine, researchers from UBC and their colleagues have demonstrated…
IMAGE: From left, U. of I. cell and developmental biology professor Jie Chen and graduate students Kook Son and Jae-Sung You discovered a new role for LRS in muscle repair. The… view more Credit: Photo by L. Brian Stauffer CHAMPAIGN, Ill. — Researchers report that a protein known to be important to protein synthesis also influences…
During the two days of the conference, leading members from renowned European research institutions will discuss how to best implement and achieve LifeTime’s mission: to make it possible for physicians to assess the molecular state of patient tissues in real time, leading to early diagnosis and effective interception of diseases. The LifeTime Opening Conference highlights…